Table 4.
Genotype | Crude OR (95% CI) | Pa | Statistical powerb | Prior probability | ||||
---|---|---|---|---|---|---|---|---|
0.25 | 0.1 | 0.01 | 0.001 | 0.0001 | ||||
RS110419 A>G | ||||||||
AG vs. AA | 0.62 (0.46–0.82) | 0.001 | 0.361 | 0.009 | 0.027 | 0.232 | 0.753 | 0.968 |
GG vs. AA | 0.65 (0.44–0.97) | 0.034 | 0.458 | 0.184 | 0.403 | 0.881 | 0.987 | 0.999 |
AG/GG vs. AA | 0.63 (0.48–0.82) | 0.0006 | 0.317 | 0.006 | 0.017 | 0.158 | 0.654 | 0.950 |
≤ 18 | 0.63 (0.42–0.94) | 0.022 | 0.377 | 0.148 | 0.343 | 0.852 | 0.983 | 0.998 |
>18 | 0.63 (0.44–0.90) | 0.011 | 0.358 | 0.081 | 0.209 | 0.744 | 0.967 | 0.997 |
Females | 0.64 (0.43–0.95) | 0.025 | 0.400 | 0.158 | 0.361 | 0.861 | 0.984 | 0.998 |
Males | 0.62 (0.43–0.89) | 0.009 | 0.329 | 0.073 | 0.190 | 0.721 | 0.963 | 0.996 |
Retroperitoneal | 0.46 (0.32–0.68) | < 0.0001 | 0.031 | 0.007 | 0.020 | 0.181 | 0.690 | 0.957 |
RS4758051 G>A | ||||||||
AG vs. GG | 0.63 (0.47–0.84) | 0.002 | 0.415 | 0.012 | 0.036 | 0.289 | 0.804 | 0.976 |
AA vs. GG | 0.68 (0.47–0.99) | 0.046 | 0.547 | 0.200 | 0.429 | 0.892 | 0.988 | 0.999 |
AA vs. GG/AG | 0.64 (0.49–0.84) | 0.001 | 0.377 | 0.009 | 0.028 | 0.240 | 0.761 | 0.970 |
>18 | 0.59 (0.41–0.84) | 0.004 | 0.236 | 0.045 | 0.123 | 0.608 | 0.940 | 0.994 |
Males | 0.60 (0.41–0.86) | 0.006 | 0.271 | 0.061 | 0.164 | 0.683 | 0.956 | 0.995 |
Retroperitoneal | 0.49 (0.34–0.72) | 0.0002 | 0.054 | 0.011 | 0.033 | 0.270 | 0.789 | 0.974 |
RS10840002 A>G | ||||||||
AG vs. AA | 0.68 (0.51–0.92) | 0.012 | 0.666 | 0.050 | 0.138 | 0.637 | 0.947 | 0.994 |
GG/AG vs. AA | 0.74 (0.56–0.97) | 0.031 | 0.764 | 0.109 | 0.268 | 0.801 | 0.976 | 0.998 |
Retroperitoneal | 0.61 (0.42–0.90) | 0.013 | 0.330 | 0.103 | 0.256 | 0.791 | 0.974 | 0.997 |
RS2168101 G>T | ||||||||
GT vs. GG | 0.51 (0.38–0.69) | < 0.0001 | 0.045 | 0.001 | 0.002 | 0.017 | 0.146 | 0.631 |
TT vs. GG | 0.51 (0.28–0.95) | 0.034 | 0.192 | 0.346 | 0.614 | 0.946 | 0.994 | 0.999 |
GT/TT vs. GG | 0.51 (0.39–0.68) | < 0.0001 | 0.035 | 0.000 | 0.001 | 0.007 | 0.067 | 0.419 |
≤ 18 | 0.66 (0.44–0.98) | 0.040 | 0.470 | 0.203 | 0.434 | 0.894 | 0.988 | 0.999 |
>18 | 0.40 (0.27–0.60) | < 0.0001 | 0.008 | 0.002 | 0.007 | 0.074 | 0.445 | 0.889 |
Females | 0.62 (0.42–0.93) | 0.020 | 0.363 | 0.143 | 0.333 | 0.846 | 0.982 | 0.998 |
Males | 0.43 (0.29–0.64) | < 0.0001 | 0.016 | 0.004 | 0.011 | 0.113 | 0.563 | 0.928 |
Retroperitoneal | 0.48 (0.32–0.72) | 0.0004 | 0.062 | 0.019 | 0.055 | 0.392 | 0.867 | 0.985 |
Mediastinum | 0.51 (0.32–0.79) | 0.003 | 0.120 | 0.068 | 0.179 | 0.706 | 0.960 | 0.996 |
PROTECTIVE GENOTYPES | ||||||||
4–5 vs. 0–3 | 0.52 (0.40–0.69) | < 0.0001 | 0.042 | 0.000 | 0.001 | 0.009 | 0.084 | 0.479 |
≤ 18 | 0.61 (0.41–0.91) | 0.014 | 0.320 | 0.118 | 0.287 | 0.816 | 0.978 | 0.998 |
>18 | 0.45 (0.31–0.66) | < 0.0001 | 0.027 | 0.006 | 0.018 | 0.171 | 0.675 | 0.954 |
Females | 0.60 (0.40–0.90) | 0.013 | 0.300 | 0.113 | 0.277 | 0.809 | 0.977 | 0.998 |
Males | 0.46 (0.32–0.68) | < 0.0001 | 0.033 | 0.007 | 0.020 | 0.181 | 0.690 | 0.957 |
Retroperitoneal | 0.41 (0.27–0.62) | < 0.0001 | 0.014 | 0.006 | 0.019 | 0.173 | 0.678 | 0.955 |
Mediastinum | 0.56 (0.36–0.86) | 0.009 | 0.211 | 0.113 | 0.277 | 0.808 | 0.977 | 0.998 |
Chi-square test was used to calculate the genotype frequency distributions.
Statistical power was calculated using the number of observations in the subgroup and the OR and P-values in this table.
The results were in bold if the 95% CI excluded 1 or P < 0.05.